Arcellx (ACLX) Total Current Liabilities (2021 - 2025)

Arcellx (ACLX) recorded quarterly Total Current Liabilities of $104.2 million in Q4 2025, down 11.99% quarter-over-quarter from $118.4 million in Q3 2025, and down 16.91% on a YoY basis from $125.4 million in Q4 2024.

Arcellx (ACLX) Total Current Liabilities (2021 - 2025) Analysis & Trends

Arcellx's Total Current Liabilities history runs 5 years deep, the most recent figure standing at $104.2 million for Q4 2025.

  • In Q4 2025, Total Current Liabilities fell 16.91% year-over-year to $104.2 million; the TTM figure through Dec 2025 stood at $104.2 million (down 16.91% YoY), while the FY2025 annual figure was $104.2 million, down 16.91% from the prior year.
  • Total Current Liabilities was $104.2 million for Q4 2025 at Arcellx, down from $118.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $173.1 million in Q3 2023 to a low of $14.4 million in Q1 2022.
  • Historically, Total Current Liabilities has averaged $99.0 million across 5 years, with a median of $112.5 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Total Current Liabilities surged 1051.18% in 2023, then plunged 43.45% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $14.8 million in 2021, then surged by 281.9% to $56.7 million in 2022, then soared by 108.56% to $118.2 million in 2023, then climbed by 6.06% to $125.4 million in 2024, then decreased by 16.91% to $104.2 million in 2025.
  • The last three Total Current Liabilities figures came in at $104.2 million (Q4 2025), $118.4 million (Q3 2025), and $121.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.70 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 636.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 13.42 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.96 Bn 91.96 Bn - 72.86 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 104.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 104.20 Mn
Sep 30, 2025 118.39 Mn
Jun 30, 2025 121.85 Mn
Mar 31, 2025 112.46 Mn
Dec 31, 2024 125.41 Mn
Sep 30, 2024 137.02 Mn
Jun 30, 2024 88.29 Mn
Mar 31, 2024 107.90 Mn
Dec 31, 2023 118.24 Mn
Sep 30, 2023 173.15 Mn
Jun 30, 2023 156.11 Mn
Mar 31, 2023 166.06 Mn
Dec 31, 2022 56.69 Mn
Sep 30, 2022 44.78 Mn
Jun 30, 2022 23.73 Mn
Mar 31, 2022 14.43 Mn
Dec 31, 2021 14.85 Mn